Largest health care pharmaceutical companies by revenue
Everything the company sold in its latest fiscal year, before any cost is taken off.
Johnson & Johnson leads the 52 health care pharmaceutical companies ranked by revenue, at DKK 642.2B, ahead of Eli Lilly (DKK 444.4B) and Merck & Co (DKK 443.2B). Figures as of 20 Nov 2026, 11:01 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 52
- First
- Johnson & JohnsonDKK 642.2B
- Median
- DKK 21.8B
- Combined market value
- DKK 33.83T
- Countries
- 10
- Not ranked
- 9no revenue on file
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | Revenue ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | DKK 642.2B | DKK 4.38T | DKK 1,821.22 | 2.04% down | 34% up | ||
| 2 | Eli LillyLLY · Health Care | DKK 444.4B | DKK 8.2T | DKK 9,211.22 | 2.29% down | 33% up | ||
| 3 | Merck & CoMRK · Health Care | DKK 443.2B | DKK 2.23T | DKK 905.43 | 3.61% down | 45% up | ||
| 4 | PfizerPFE · Health Care | DKK 426.6B | DKK 1.07T | DKK 187.75 | 1.85% down | 15% up | ||
| 5 | AbbVieABBV · Health Care | DKK 417B | DKK 3.42T | DKK 1,933.03 | 0.86% down | 25% up | ||
| 6 | AstraZenecaAZN · Health Care | DKK 400.5B | DKK 1.85T | DKK 1,195.85 | 1.87% down | 1% up | ||
| 7 | NovartisNVS · Health Care | DKK 371.8B | DKK 1.95T | DKK 1,030.94 | 2.57% down | 25% up | ||
| 8 | SanofiSNY · Health Care | DKK 330B | DKK 754B | DKK 314.01 | 2.25% down | 4% down | ||
| 9 | Bristol-Myers SquibbBMY · Health Care | DKK 328.6B | DKK 813B | DKK 397.73 | 2.05% down | 30% up | ||
| 10 | Novo NordiskNVO · Health Care | DKK 312.7B | DKK 1.17T | DKK 265.00 | 1.42% down | 17% down | ||
| 11 | Abbott LaboratoriesABT · Health Care | DKK 302.2B | DKK 1.23T | DKK 708.13 | 0.58% down | 16% down | ||
| 12 | GSKGSK · Health Care | DKK 295.6B | DKK 653.5B | DKK 326.01 | 1.56% down | 5% up | ||
| 13 | Takeda PharmaceuticalTAK · Health Care | DKK 192.4B | DKK 466.3B | DKK 145.96 | 0.66% up | 51% up | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | DKK 117.7B | DKK 306.6B | DKK 262.75 | 8.74% down | 74% up | ||
| 15 | Regeneron PharmaceuticalsREGN · Health Care | DKK 97.8B | DKK 651.2B | DKK 6,294.84 | 2.35% down | 28% up | ||
| 16 | ViatrisVTRS · Health Care | DKK 97.5B | DKK 155.4B | DKK 135.53 | 1.97% down | 99% up | ||
| 17 | Vertex PharmaceuticalsVRTX · Health Care | DKK 81.8B | DKK 900B | DKK 3,549.58 | 2.94% down | 27% up | ||
| 18 | ZoetisZTS · Health Care | DKK 64.5B | DKK 223.8B | DKK 550.78 | 5.59% down | 26% down | ||
| 19 | GrifolsGRFS · Health Care | DKK 56.9B | DKK 38B | DKK 55.90 | 3.19% down | 0% up | ||
| 20 | BeOne MedicinesONC · Health Care | DKK 36.4B | DKK 311.3B | DKK 2,724.94 | 0.97% down | 16% up | ||
| 21 | Elanco Animal HealthELAN · Health Care | DKK 32.1B | DKK 89.6B | DKK 179.23 | 1.54% down | 26% up | ||
| 22 | Jazz PharmaceuticalsJAZZ · Health Care | DKK 29.1B | DKK 103.5B | DKK 1,611.99 | 4.57% down | 41% up | ||
| 23 | GenmabGMAB · Health Care | DKK 25.4B | DKK 215.9B | DKK 350.08 | 0.75% up | 70% up | ||
| 24 | Alnylam PharmaceuticalsALNY · Health Care | DKK 25.3B | DKK 135B | DKK 1,007.76 | 1.06% down | 66% down | ||
| 25 | Dr. Reddy's LaboratoriesRDY · Health Care | DKK 24.4B | DKK 84.3B | DKK 101.10 | 1.00% down | 8% up | ||
| 26 | BioMarin PharmaceuticalBMRN · Health Care | DKK 22B | DKK 81.1B | DKK 418.73 | 0.02% down | 17% up | ||
| 27 | United TherapeuticsUTHR · Health Care | DKK 21.7B | DKK 162.3B | DKK 3,811.65 | 3.16% down | 22% up | ||
| 28 | Amneal PharmaceuticalsAMRX · Health Care | DKK 20.6B | DKK 50.8B | DKK 145.83 | 2.24% down | 90% up | ||
| 29 | Royalty PharmaRPRX · Health Care | DKK 16.2B | DKK 265.5B | DKK 461.68 | 1.38% down | 79% up | ||
| 30 | PTC TherapeuticsPTCT · Health Care | DKK 11.8B | DKK 33.2B | DKK 397.63 | 3.16% down | 21% down | ||
| 31 | AlkermesALKS · Health Care | DKK 10.1B | DKK 52.9B | DKK 314.83 | 1.43% down | 66% up | ||
| 32 | Legend BiotechLEGN · Health Care | DKK 7B | DKK 21.3B | DKK 109.76 | 0.92% down | 41% down | ||
| 33 | Madrigal PharmaceuticalsMDGL · Health Care | DKK 6.5B | DKK 62.8B | DKK 2,704.76 | 0.34% down | 27% down | ||
| 34 | Ionis PharmaceuticalsIONS · Health Care | DKK 6.4B | DKK 30.9B | DKK 185.57 | 0.62% down | 63% down | ||
| 35 | Arrowhead PharmaceuticalsARWR · Health Care | DKK 5.7B | DKK 42.1B | DKK 297.58 | 1.25% up | 13% up | ||
| 36 | Ascendis PharmaASND · Health Care | DKK 5.4B | DKK 114.5B | DKK 1,745.00 | 5.32% down | 29% up | ||
| 37 | Corcept TherapeuticsCORT · Health Care | DKK 5.2B | DKK 48.5B | DKK 443.00 | 4.15% down | 10% down | ||
| 38 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | DKK 4.6B | DKK 50.1B | DKK 637.67 | 1.59% down | 129% up | ||
| 39 | Axsome TherapeuticsAXSM · Health Care | DKK 4.4B | DKK 48.7B | DKK 924.99 | 1.25% up | 6% down | ||
| 40 | TG TherapeuticsTGTX · Health Care | DKK 4.2B | DKK 66.9B | DKK 442.32 | 1.88% down | 117% up | ||
| 41 | InsmedINSM · Health Care | DKK 4.1B | DKK 216.1B | DKK 984.85 | 20.58% up | 40% down | ||
| 42 | Mirum PharmaceuticalsMIRM · Health Care | DKK 3.6B | DKK 42.5B | DKK 651.14 | 3.27% up | 34% up | ||
| 43 | BridgeBio PharmaBBIO · Health Care | DKK 3.4B | DKK 103.8B | DKK 532.99 | 0.22% up | 21% up | ||
| 44 | Travere TherapeuticsTVTX · Health Care | DKK 3.3B | DKK 31.6B | DKK 329.28 | 3.86% down | 45% up | ||
| 45 | Ligand PharmaceuticalsLGND · Health Care | DKK 1.8B | DKK 39.1B | DKK 1,956.20 | 3.94% down | 50% up | ||
| 46 | Rhythm PharmaceuticalsRYTM · Health Care | DKK 1.3B | DKK 55.2B | DKK 796.28 | 1.88% down | 18% up | ||
| 47 | CytokineticsCYTK · Health Care | DKK 600.2M | DKK 48.9B | DKK 350.83 | 0.27% up | 19% down | ||
| 48 | Protagonist TherapeuticsPTGX · Health Care | DKK 313.7M | DKK 55.2B | DKK 845.50 | 2.47% down | 51% up | ||
| 49 | Roivant SciencesROIV · Health Care | DKK 56.3M | DKK 192.4B | DKK 265.61 | 0.59% up | 91% up | ||
| 50 | Dianthus TherapeuticsDNTH · Health Care | DKK 13.9M | DKK 32.6B | DKK 578.33 | 1.01% up | 108% up | ||
| 51 | Spyre TherapeuticsSYRE · Health Care | DKK 0 | DKK 63.2B | DKK 665.59 | 3.77% down | 332% up | ||
| 52 | Praxis Precision MedicinesPRAX · Health Care | DKK 0 | DKK 59.2B | DKK 2,119.55 | 1.87% up | 86% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 6.8175 DKK). 9 companies have no revenue on file and are not ranked here.
Questions and answers
Which health care pharmaceutical companies rank first by revenue?
Johnson & Johnson (DKK 642.2B), Eli Lilly (DKK 444.4B) and Merck & Co (DKK 443.2B) are the top three of the 52 health care pharmaceutical companies ranked by revenue as of 20 Nov 2026, 11:01 UTC.
How many health care pharmaceutical companies are in this ranking?
52 are ranked by revenue. 9 more have no revenue on file and are left out rather than ranked at zero.
What are these health care pharmaceutical companies worth together?
The 52 health care pharmaceutical companies ranked by revenue have a combined market value of DKK 33.83T as of 20 Nov 2026, 11:01 UTC.
What does ranking by revenue measure?
Everything the company sold in its latest fiscal year, before any cost is taken off.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest health care pharmaceutical companies by revenue”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=revenue
Underlying data: Yahoo Finance; SEC EDGAR.